Nifty99000 100%

Sensex99000 100%

Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
RSS

News

Chemists down shutters, warn of indefinite strike

Author: IANS/Wednesday, May 31, 2017/Categories: Healthcare

Chemists down shutters, warn of indefinite strike

New Delhi (IANS) An estimated eight lakh chemists downed shutters across India on May 30 against new government norms which they said would badly hit their business and warned of an indefinite strike if these were not withdrawn. The chemists are up in arms against new rules which demand e-portal registration and updating of every purchase and sale of medicines, saying these would create hurdles in their functioning.

The All India Organisation of Chemists and Druggists (AIOCD) and the Retailers and Distributors Chemist Association (RDCA), the two main bodies, questioned the need for such norms when only 10% of the retailers in the country use computers. 
 
 Instead of demanding details of purchase and sale of medicines on the e-portal, the government should come up with a bar code system on medicines, they said.  
 
 "There is a need for the government to be pragmatic. If the government wants details about purchases and sales and genuineness of quality, they should come up with a bar code system," Rajeev Bhatia, Organising Secretary of RDCA, said.
 
 Basant Goel, a senior member of both AIOCD and RDCA, said about 50% of the total 15 lakh chemists all over the country remained closed on Tuesday.
 
"The maximum impact was felt in Delhi where up to 70% of all chemists downed their shutters," Goel said. "The impact was more in some states, less in some. But our message was clear." RDCA said nearly 14,000 chemist shops were shut in Delhi alone on Tuesday but nearly 3,000 were allowed to do business keeping patients' interests in mind. A total of 8.5 million employees across India are directly involved in retail pharmacy business, Jagannath Shinde, President of AIOCD, said in Mumbai. He said 72,000 of the striking retailers were from Maharashtra.

Instead of acting against online medical suppliers, against whom the association had been protesting for two years, Bhatia asked why chemists were being told to pay one% on all medicine sales to the government. Goel told IANS: "It seems that due to the new norms more than 40% chemists in rural areas will have to shut down. These norms are encouraging the unethical practice of online medicine suppliers." 
 
 Banning online medicine sale is among the demands of the retailers, who say online sellers supply drugs without prescription.
  
 The new norms insist on sale of medicines only on the strength of prescriptions from qualified medicos. The chemists argue this will affect their business as over 60% of rural India has no qualified doctors. Shinde said the new norms would lead to mayhem in rural India which lacks adequate internet connectivity and regular power supply. 

He said presently Ayurvedic, Homeopathic and Unani doctors combine allopathic medicines to provide timely treatment to the rural masses, but they won't be permitted to do this under the new law. Shinde warned that if the authorities don't respond to the just demands of the chemists, they would be forced to launch an indefinite agitation after a couple of months.
 

Print Rate this article:
No rating

Number of views (187)/Comments (0)

S Vijaykrishnan
S Vijaykrishnan

IANS

Other posts by IANS
Contact author

Leave a comment

Name:
Email:
Comment:
Add comment

Name:
Email:
Subject:
Message:
x

Videos

Ask the Finapolis.

I'm not a robot
 
Dharmendra Satpathy
Col. Sanjeev Govila (retd)
Hum Fauji Investments
 
The Finapolis' expert answers your queries on investments, taxation and personal finance. Want advice? Submit your Question above
Want to Invest
 
 

Categories

Disclaimer

The technical studies / analysis discussed here can be at odds with our fundamental views / analysis. The information and views presented in this report are prepared by Karvy Consultants Limited. The information contained herein is based on our analysis and upon sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither Karvy nor Karvy Consultants nor any person connected with any associate companies of Karvy accepts any liability arising from the use of this information and views mentioned in this document. The author, directors and other employees of Karvy and its affiliates may hold long or short positions in the above mentioned companies from time to time. Every employee of Karvy and its associate companies is required to disclose his/her individual stock holdings and details of trades, if any, that they undertake. The team rendering corporate analysis and investment recommendations are restricted in purchasing/selling of shares or other securities till such a time this recommendation has either been displayed or has been forwarded to clients of Karvy. All employees are further restricted to place orders only through Karvy Consultants Ltd. This report is intended for a restricted audience and we are not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities.

Subscribe For Free

Get the e-paper free